Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
3.170
+0.010 (0.32%)
Feb 21, 2025, 4:00 PM EST - Market closed
Daré Bioscience Employees
As of December 31, 2023, Daré Bioscience had 26 total employees, including 23 full-time and 3 part-time employees. The number of employees decreased by 4 or -13.33% compared to the previous year.
Employees
26
Change (1Y)
-4
Growth (1Y)
-13.33%
Revenue / Employee
$72,358
Profits / Employee
-$138,645
Market Cap
27.58M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
DARE News
- 16 days ago - Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development - GlobeNewsWire
- 6 weeks ago - Daré Bioscience to Participate in the Women's Health Series at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Daré Bioscience, Inc. (DARE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 3 months ago - Daré Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024 - GlobeNewsWire
- 4 months ago - Daré Bioscience Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health - GlobeNewsWire
- 4 months ago - Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC - GlobeNewsWire
- 6 months ago - Daré Bioscience, Inc. (DARE) Q2 2024 Earnings Call Transcript - Seeking Alpha